Arterial Hypertension
Conditions
Interventions
The objective of the study is to evaluate the effectiveness of the application for mobile devices in adherence to drug therapy in the elderly with Hypertension treated in primary care, through a rando
L01.224.900.685
Sponsors
Universidade de Brasília
Secretaria de Saúde do Distrito Federal
Eligibility
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: Elderly aged 65 years or older, with stage 1 or 2 SAH; with uncontrolled blood pressure in at least 2 consultations; who use at least 1 daily medication for at least 1 year; who has a cell phone with memory space and internet access; elderly people classified in Profile 1 and 2 of functionality for care purposes, in the Line of Care for Comprehensive Health Care for the Elderly; not practicing physical activity or showing insufficient physical activity, assessed using the short version of the International Physical Activity Questionnaire (IPAQ).
Exclusion criteria
Exclusion criteria: Illiterate elderly will be excluded; who have some physical or intellectual impediment that prevents them from using the application or mobile device; patients with Chronic Kidney Disease and who have a self-reported medical diagnosis of dementia, delirium, psychotic or substance-related mental disorders according to DSM-5 criteria and those who do not complete the research steps; elderly people who present cognitive impairments evaluated through the 10-CD Cognitive Test in which the cutoff scores used for exclusion will be: 17 for the illiterate; 22 for seniors with between 1 and 4 years of schooling; 24 for those with between 5 and 8 years of schooling and 26 for those with 9 or more years of schooling; elderly people with mobility deficits using the Timed Up-and-Go (TUG) scale over 20 seconds, a timed test that assesses gait speed, balance and risk of falling; seniors participating in another clinical trial; research study or exercise program where they perform similar balance and strength activities; and those who have mobility limitations or use walking devices; diagnosis of progressive neurological disease or other acute or unstable medical condition that precludes performance of the exercises.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find an improvement in the rate of adherence to drug therapy assessed by the Morisky Therapeutic Adherence Scale (MMAS-8) of at least 20%. Data will be collected 30 days before the intervention and up to 30 days after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find an improvement in the self-care score, assessed by the Brazilian Version Hypertension Self-Care Scale (EAC-HI) by at least 20%. Data will be collected 30 days before the intervention and up to 30 days after the intervention.;It is expected to find an improvement in blood pressure levels evaluated according to the Brazilian Guidelines on Arterial Hypertension, decreasing systolic and diastolic blood pressure by at least 2%. Data will be collected 30 days before the intervention and up to 30 days after the intervention.;It is expected to find an improvement in biochemical parameters such as: plasma potassium, fasting glucose (FG), lipid profile, serum creatinine, glomerular filtrate rate, serum uric acid and type 1 urinalysis evaluated according to the Brazilian Guidelines for Arterial Hypertension-2020. Data will be collected 30 days before the intervention and up to 30 days after the intervention. | — |
Countries
Brazil
Contacts
Public ContactAlayne Pereira
Universidade de Brasília
Outcome results
None listed